Showing results (101-110 of 115) with videos related to
Sort By:
Pageof 12
Pathology, Research and Practice|June 27, 2022
The Semaphorin 3A-AKT axis-mediated cell proliferation in salivary gland morphogenesis and adenoid cystic carcinoma pathogenesisShinsuke Fujii, Tatsufumi Fujimoto, Kana Hasegawa, et al.The ISME Journal|February 15, 2020
Comparative genomics: Dominant coral-bacterium Endozoicomonas acroporae metabolizes dimethylsulfoniopropionate (DMSP)Kshitij Tandon, Chih-Ying Lu, Pei-Wen Chiang, et al.Microbiome|August 25, 2020
A ubiquitous subcuticular bacterial symbiont of a coral predator, the crown-of-thorns starfish, in the Indo-PacificNaohisa Wada, Hideaki Yuasa, Rei Kajitani, et al.Digestive Diseases (Basel, Switzerland)|August 8, 2020
Impact of Anti-GPIIb/IIIa Antibody-Producing B Cells as a Predictor of the Response to Lusutrombopag in Thrombocytopenic Patients with Liver DiseaseNaohisa Wada, Haruki Uojima, Takashi Satoh, et al.BMC Biology|October 21, 2022
Comparative genomic and transcriptomic analyses of trans-kingdom pathogen Fusarium solani species complex reveal degrees of compartmentalizationDaphne Z Hoh, Hsin-Han Lee, Naohisa Wada, et al.Science Advances|November 22, 2023
Similar but different: Characterization of <i>dddD</i> gene-mediated DMSP metabolism among coral-associated <i>Endozoicomonas</i>Yu-Jing Chiou, Ya-Fan Chan, Sheng-Ping Yu, et al.Science Advances|July 20, 2022
High-resolution spatial and genomic characterization of coral-associated microbial aggregates in the coral <i>Stylophora pistillata</i>Naohisa Wada, Ming-Tsung Hsu, Kshitij Tandon, et al.Microbiome|January 6, 2019
Metagenomic, phylogenetic, and functional characterization of predominant endolithic green sulfur bacteria in the coral Isopora paliferaShan-Hua Yang, Kshitij Tandon, Chih-Ying Lu, et al.Communications Biology|June 20, 2024
Common dietary emulsifiers promote metabolic disorders and intestinal microbiota dysbiosis in miceSuraphan Panyod, Wei-Kai Wu, Chih-Ting Chang, et al.Hepatology Research : the Official Journal of the Japan Society of Hepatology|November 11, 2021
Safety and efficacy of atezolizumab plus bevacizumab in patients with unresectable hepatocellular carcinoma in early clinical practice: A multicenter analysisMakoto Chuma, Haruki Uojima, Nobuhiro Hattori, et al.Pageof 12